Genetic modification therapies, significantly gene therapy and RNA therapy, have existed for many years, with very little clinical success. However, recent enhancements in these therapies, together with higher delivery systems, additional economical and sturdy gene expression constructs, precise polymer editing tools, have brought this industry to the forefront, and it’s currently poised for explosive growth within the coming back years.
The global Genetic Modification Therapies market is expected to exceed more than US$ 10.70 Billion by 2028 at a CAGR of 34% in the given forecast period.
Because of the potentially curative nature of those medicines there’s monumental potential in several applications, starting from cancer to neurology to rare diseases. Genetic modification therapies represent consecutive wave of medicines with monumental potential for treating and curing draining and high diseases. As a result of its wide scope, genetic modification therapy can play a vital role within the future world medical economy.
Continuing advances in key technologies like DNA editing, viral design and production, and gene expression, further as a pressing medical want in several serious and enervating disorders, are driving the expansion of the marketplace for genetic modification therapies. Developments in these multidisciplinary fields promise to advance the genetic modification therapies trade and build distinctive market opportunities.
The overall market is anticipated to witness important growth in opportunities for a spread of stakeholders within the returning decade. it’s necessary to spotlight that many technology suppliers, reaching to develop and / or support the event of gene therapies, with improved effectiveness and safety, have designed and already introduced advanced platforms for the engineering of vectors. Innovation during this domain has additionally semiconductor diode to the invention of novel molecular targets and strong the analysis pipelines of corporations targeted during this house. the potential to focus on numerous therapeutic areas is taken into account to be amongst the foremost outstanding growth drivers of this market.
Market Insights
The global Genetic Modification Therapies market is segregated on the basis of Platform Technology as Gene editing, Gene Therapies, Genetically Modified Cell Therapies, and RNA Therapies. Based on Delivery Technologies the global Genetic Modification Therapies market is segmented in AAV, Adenovirus, Lentivirus, Retrovirus, Other Viral, and Nonviral… Based on End-User Industry the global Genetic Modification Therapies market is segmented in Hospitals, Diagnostics and Testing Laboratories, Academic and Research Organizations, and Others.
Based on Disease, the global Genetic Modification Therapies market is segmented in Cardiology, Oncology, Ophthalmology, Hematology, Musculoskeletal, Neurology, Rare Diseases, Other Indications.
The global Genetic Modification Therapies market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Genetic Modification Therapies market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
4D Molecular Therapeutics, Abeona Therapeutics, Beam Therapeutics, Casebia Therapeutics, Editas Medicine, Fate Therapeutics, GE Healthcare, Hitachi Chemical Advanced Therapeutics, Immunocore, Jivana Biotechnology, and others are among the major players in the global Genetic Modification Therapies market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Genetic Modification Therapies Market has been segmented as below:
Genetic Modification Therapies Market, By Platform Technology
Genetic Modification Therapies Market, By Delivery Technologies
Genetic Modification Therapies Market, By End-User Industry
Genetic Modification Therapies Market, By Disease
Genetic Modification Therapies Market, By Region
Genetic Modification Therapies Market, By Company
The report covers:
Report Scope:
The global Genetic Modification Therapies market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Genetic Modification Therapies market share. Major industry players with significant revenue share include 4D Molecular Therapeutics, Abeona Therapeutics, Beam Therapeutics, Casebia Therapeutics, Editas Medicine, Fate Therapeutics, GE Healthcare, Hitachi Chemical Advanced Therapeutics, Immunocore, Jivana Biotechnology, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Veterinary Surgical Instruments Market
Parkinson’s Disease Treatment Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Genetic Modification Therapies Market, By Platform Technology
5.1 Introduction
5.2 Gene editing
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Gene Therapies
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Genetically Modified Cell Therapies
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 RNA Therapies
5.5.1 Market Overview
5.5.2 Market Size and Forecast
6. Genetic Modification Therapies Market, By Delivery Technologies
6.1 Introduction
6.2 AAV
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Adenovirus,
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Lentivirus,
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Retrovirus,
6.5.1 Market Overview
6.5.2 Market Size and Forecast
6.6 Other Viral
6.6.1 Market Overview
6.6.2 Market Size and Forecast
6.7 Nonviral.
6.7.1 Market Overview
6.7.2 Market Size and Forecast
7. Genetic Modification Therapies Market, By End-User Industry
7.1 Introduction
7.2 Hospitals
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Diagnostics and Testing Laboratories
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Academic and Research Organizations
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 Others
7.5.1 Market Overview
7.5.2 Market Size and Forecast
8. Genetic Modification Therapies Market, By Disease
8.1 Introduction
8.2 Cardiology,
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 Oncology,
8.3.1 Market Overview
8.3.2 Market Size and Forecast
8.4 Ophthalmology,
8.4.1 Market Overview
8.4.2 Market Size and Forecast
8.5 Hematology,
8.5.1 Market Overview
8.5.2 Market Size and Forecast
8.6 Musculoskeletal,
8.6.1 Market Overview
8.6.2 Market Size and Forecast
8.7 Neurology,
8.7.1 Market Overview
8.7.2 Market Size and Forecast
8.8 Rare Diseases
8.8.1 Market Overview
8.8.2 Market Size and Forecast
8.9 Other Indications
8.9.1 Market Overview
8.9.2 Market Size and Forecast
9. Genetic Modification Therapies Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 North America Genetic Modification Therapies, By Platform Technology
9.2.2 North America Genetic Modification Therapies, By Delivery Technologies
9.2.3 North America Genetic Modification Therapies, By End-User Industry
9.2.4 North America Genetic Modification Therapies, By Disease
9.3 Europe
9.3.1 Europe Genetic Modification Therapies, By Platform Technology
9.3.2 Europe Genetic Modification Therapies, By Delivery Technologies
9.3.3 Europe Genetic Modification Therapies, By End-User Industry
9.3.4 Europe Genetic Modification Therapies, By Disease
9.4 Asia-Pacific
9.4.1 Asia-Pacific Genetic Modification Therapies, By Platform Technology
9.4.2 Asia-Pacific Genetic Modification Therapies, By Delivery Technologies
9.4.3 Asia-Pacific Genetic Modification Therapies, By End-User Industry
9.4.4 Asia-Pacific Genetic Modification Therapies, By Disease
9.5 Rest of the World
9.5.1 Rest of the World Genetic Modification Therapies, By Platform Technology
9.5.2 Rest of the World Genetic Modification Therapies, By Delivery Technologies
9.5.3 Rest of the World Genetic Modification Therapies, By End-User Industry
9.5.4 Rest of the World Genetic Modification Therapies, By Disease
10. Competitive Insights
10.1 Key Insights
10.2 Company Market Share Analysis
10.3 Strategic Outlook
10.3.1 Mergers & Acquisitions
10.3.2 New Product Development
10.3.3 Portfolio/Production Capacity Expansions
10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5 Others
11. Company Profiles
11.1 4D Molecular Therapeutics
11.1.1 Company Overview
11.1.2 Product/Service Landscape
11.1.3 Financial Overview
11.1.4 Recent Developments
11.2 Abeona Therapeutics
11.2.1 Company Overview
11.2.2 Product/Service Landscape
11.2.3 Financial Overview
11.2.4 Recent Developments
11.3 Beam Therapeutics,
11.3.1 Company Overview
11.3.2 Product/Service Landscape
11.3.3 Financial Overview
11.3.4 Recent Developments
11.4 Casebia Therapeutics,
11.4.1 Company Overview
11.4.2 Product/Service Landscape
11.4.3 Financial Overview
11.4.4 Recent Developments
11.5 Editas Medicine,
11.5.1 Company Overview
11.5.2 Product/Service Landscape
11.5.3 Financial Overview
11.5.4 Recent Developments
11.6 Fate Therapeutics,
11.6.1 Company Overview
11.6.2 Product/Service Landscape
11.6.3 Financial Overview
11.6.4 Recent Developments
11.7 GE Healthcare,
11.7.1 Company Overview
11.7.2 Product/Service Landscape
11.7.3 Financial Overview
11.7.4 Recent Developments
11.8 Hitachi Chemical Advanced Therapeutics,
11.8.1 Company Overview
11.8.2 Product/Service Landscape
11.8.3 Financial Overview
11.8.4 Recent Developments
11.9 Immunocore,
11.9.1 Company Overview
11.9.2 Product/Service Landscape
11.9.3 Financial Overview
11.9.4 Recent Developments
11.10 Jivana Biotechnology,
11.10.1 Company Overview
11.10.2 Product/Service Landscape
11.10.3 Financial Overview
11.10.4 Recent Developments
The Genetic Modification Therapies Market has been segmented as below:
Genetic Modification Therapies Market, By Platform Technology
Genetic Modification Therapies Market, By Delivery Technologies
Genetic Modification Therapies Market, By End-User Industry
Genetic Modification Therapies Market, By Disease
Genetic Modification Therapies Market, By Region
Genetic Modification Therapies Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
